Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram versus placebo for change in neuroticism traits
IRCT20211208053331N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in neuroticism comparing Escitalopram with Placebo (2 arms). Primary endpoints: Flexibility, Responsibility and 2 more. Started Jul 2022; status: completed.
02
Drugs
escitalopram
03
Conditions
neuroticism
Beyond the preview
Go deeper on IRCT20211208053331N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211208053331N1.